Why President Lee Jae-myung Is Pushing For Abortion Pills Without A Law

Why President Lee Jae-myung Is Pushing For Abortion Pills Without A Law

Imagine paying $370 on a sketchy black-market website for a basic, essential medication that women in France get for free. Imagine doing that because your government has been too terrified to write a single sentence of medical regulation for six years.

That is the daily reality for women in South Korea.

In 2019, the country’s Constitutional Court ruled that the nation's decades-old abortion ban was unconstitutional. It ordered lawmakers to draft a new regulatory framework. Since then? Absolute silence. A total legislative void.

On July 14, 2026, South Korean President Lee Jae-myung finally lost his patience. During a Cabinet meeting at the Blue House, he openly called his own government "irresponsible" for leaving women in a dangerous legal gray zone. His solution is radical, messy, and already sparking a massive fight with the medical establishment. He wants doctors to just start prescribing the abortion pill, Mifepristone, even if the government hasn't figured out the legal paperwork yet.

Let's look at why this is happening, why it’s so messy, and what it actually means for women's healthcare.

To understand why Lee Jae-myung is throwing a wrench into the system, you have to look at the bizarre legal limbo South Korea has been stuck in since January 1, 2021.

Technically, abortion is completely decriminalized. You cannot go to jail for getting one, and doctors cannot go to jail for performing one. But because the National Assembly has repeatedly dodged the debate over gestational limits—arguing endlessly over whether the limit should be 14 weeks, 22 weeks, or something else entirely—there is no active medical law.

Without a law, there is no official pathway for the Ministry of Food and Drug Safety to approve and distribute Mifepristone, commonly known as Mifegyne.

So, what happens? Women don't stop needing abortions. They just find other ways.

They turn to online black markets, paying up to 500,000 Korean won (about $370 USD) to buy imported, unregulated pills from shady overseas dealers. They take these drugs without doctor supervision, without knowing if they are counterfeits, and without any safety net if something goes wrong.

President Lee pointed this out directly. He noted that keeping the drug unapproved doesn't stop abortions; it just forces women to risk their lives. He argued that refusing to act because the debate is too difficult is simply government negligence.

Lee Jae-myung's pragmatic shortcut

President Lee’s proposal is basically a massive bypass of the legislative branch. He suggested that instead of waiting for a deeply divided parliament to agree on a perfect law, the government should just give medical professionals the green light to use their own judgment.

"If we ask how many weeks of abortion should be allowed, the entire country would erupt in chaos," Lee said during the meeting. He's right. The political factions in Korea are so polarized on this issue that a consensus is practically impossible anytime soon.

His logic is simple. Doctors already make life-and-death decisions in emergency rooms and operating theaters every single day. They evaluate patients, weigh risks, and make medical calls. Why not trust them to decide when a patient can safely use Mifepristone?

"Laws aren't absolute truths," Lee argued, pushing for a flexible, patient-first approach rather than waiting for rigid bureaucratic rules that might never come.

It’s an incredibly pragmatic view. It’s also incredibly risky.

💡 You might also like: attorney general eric t schneiderman

The medical community is not having it

Predictably, doctors are terrified.

Within twenty-four hours of Lee’s comments, the Korean Society of Obstetrics and Gynecology issued a blistering statement calling the president's idea "extremely dangerous".

Their concern isn't necessarily ideological; it's legal and practical.

If a doctor prescribes an unapproved drug under "discretionary judgment," who carries the liability if a patient suffers severe complications? In a country with a highly litigious medical environment, doctors don't want to be the ones holding the bag if a patient sues over a prescription that has no formal legal backing.

The medical community is demanding clear guidelines. They want to know the exact gestational limits, the exact protocols for managing side effects, and they want legal immunity for acting in good faith. Without those protections, most gynecologists will likely refuse to touch Mifepristone, leaving the president's plan dead on arrival.

Following the backlash, Prime Minister Han Seong-sook scrambled to call an emergency meeting of the Ministry of Health, the Ministry of Justice, and the Ministry of Food and Drug Safety to figure out how to actually execute the president's directive without triggering a medical strike.

The financial ripple effect

While politicians and doctors argue, the stock market did what it always does: it found a way to profit.

As soon as President Lee made his remarks, shares of Hyundai Pharm skyrocketed. Why? Because Hyundai Pharm has been holding the exclusive domestic distribution rights for Mifegyne in South Korea, waiting years for the green light to sell it.

The corporate side of this story shows just how ready the market is for a shift. The drug is already designated as an essential medicine by the World Health Organization and used in over 100 countries. The infrastructure to distribute it safely is there; it's just being choked by political cowardice.

Where do we go from here?

This fight isn't going away. If you're looking at South Korea's reproductive rights timeline, we are at a critical breaking point. Here is what needs to happen next for this to actually work:

  • Temporary medical guidelines must be established immediately. The Ministry of Health and Welfare cannot just tell doctors to "use their discretion". They must issue a temporary protocol that shields doctors from legal liability while establishing basic safety baselines.
  • The Ministry of Food and Drug Safety needs to fast-track Mifepristone approval. Relying on unregulated imports is a public health crisis. Getting legitimate, tested pharmaceutical supplies into clinics is the only way to kill the dangerous online black market.
  • Pressure must stay on the National Assembly. President Lee's shortcut is a bandage, not a cure. A real, codified law that outlines healthcare coverage, gestational limits, and patient rights is still the only permanent solution.

President Lee's move might be messy, but it forced a stale, cowardly debate back into the spotlight. For the thousands of women currently risking their health with black-market imports, that spotlight is long overdue.

DG

Dominic Garcia

As a veteran correspondent, Dominic Garcia has reported from across the globe, bringing firsthand perspectives to international stories and local issues.